verified SJR 0,684 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Lippincott Williams and Wilk...

workspace_premium Q2 — Pharmacology lock Subscription

Journal of Cardiovascular Pharmacology

Journal of Cardiovascular Pharmacology is a journal indexed in SJR in Pharmacology and Cardiology and Cardiovascular Medicine with an H index of 111. It has an SJR impact factor of 0,684 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,684.

Journal of Cardiovascular Pharmacology focuses its scope in these topics and keywords: cell, inhibitor, treatment, improves, myocardial, function, protein, coupled, cardiac, arterial, ...

ISSN: 0160-2446

Publisher: Lippincott Williams and Wilkins

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,684 Q2

H-index 111

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,684

H-index

111

Docs (year)

167

Docs 3y

538

Total refs

6201

Cites 3y

1230

Citable 3y

491

Cites/Doc 2y

2.07

Ref/Doc

37.13

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bepridil Block of Recombinant Human Cardiac IKs Current Shows a Time-Dependent Unblock

Vascular Renin-Angiotensin System and Vascular Protection

Chronic Treatment with Rilmenidine in Spontaneously Hypertensive Rats: Differences between Two Schedules of Administration

Changes of Central Norepinephrine, beta-Endorphin, LEU-Enkephalin, Peripheral Arginine-Vasopressin, and Angiotensin II Levels in Acute and Chronic Phases of Sino-Aortic Denervation in Rats

Cardiovascular Risk and Safety Evaluation of a Dual Peroxisome Proliferator-Activated Receptor-Alpha/Gamma Agonist, Aleglitazar, in Patients With Type 2 Diabetes

Cardioprotective Effects of Transforming Growth Factor-beta1 During Early Reoxygenation or Reperfusion Are Mediated by p42/p44 MAPK

Cardioprotective Effect of Zofenopril in Perfused Rat Heart Subjected to Ischemia and Reperfusion

Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction

Candesartan and Arterial Baroreflex Sensitivity and Sympathetic Nerve Activity in Patients with Mild Heart Failure

Calyculin A and Outward K+ Channel Currents in Rat Tail Artery Smooth Muscle Cells

Calcium Dynamics and Vasomotion in Rat Mesenteric Arteries

Blockade of Angiotensin II Receptors Inhibits the Increase in Blood Pressure Induced by Insulin

SHOW MORE ARTICLES

Binding Properties of beta-Blockers at Recombinant beta1-, beta2-, and beta3-Adrenoceptors

17-beta Estradiol Independently Regulates Erythropoietin Synthesis and NOS Activity during Hypoxia

AT1 and AT2-Receptor Antagonists Inhibit Ang II-Mediated Facilitation of Noradrenaline Release in Human Atria

Asynchronism of the Recovery of Baroreflex Sensitivity, Blood Pressure, and Consciousness from Anesthesia in Rats

Association Between Vascular Tolerance and Platelet Upregulation: Comparison of Nonintermittent Administration of Pentaerithrityltetranitrate and Glyceryltrinitrate

Arteries and Veins Desensitize Differently to Endothelin

Artemisinin Attenuated Atherosclerosis in High-Fat Diet-Fed ApoE-/- Mice by Promoting Macrophage Autophagy Through the AMPK/mTOR/ULK1 Pathway

Anti-anginal Effect of Fasudil, a Rho-Kinase Inhibitor, in Patients With Stable Effort Angina: A Multicenter Study

An Omega-3 Epoxide of Docosahexaenoic Acid Lowers Blood Pressure in Angiotensin-II-Dependent Hypertension

Altered Expression of Isoforms of Myosin Heavy Chain mRNA in the Failing Rat Heart Is Ameliorated by Chronic Treatment with an Endothelin Receptor Antagonist

Adenovirus Gene Transfer of Recombinant Endothelial Nitric Oxide Synthase Enhances Contractile Function in Ventricular Myocytes

Acetylcholine-Induced Relaxation of Rabbit Basilar Artery In Vitro Is Rapidly Reduced by Reactive Oxygen Species in Acute Hyperglycemia

FAQs

Journal of Cardiovascular Pharmacology has an SJR of 0,684 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Cardiovascular Pharmacology is 24%.

Journal of Cardiovascular Pharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Cardiovascular Pharmacology?

What is the APC / publication cost?

What is the acceptance rate?